Martin Fan
Stock Analyst at Wedbush
(4.69)
# 757
Out of 4,405 analysts
53
Total ratings
57.5%
Success rate
43.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Martin Fan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RNAC Cartesian Therapeutics | Maintained: Buy | $38 | $9.51 | +299.58% | 5 | May 27, 2026 | |
| ARTV Artiva Biotherapeutics | Maintained: Buy | $40 | $8.54 | +368.38% | 4 | May 21, 2026 | |
| TRAX First Tracks Biotherapeutics | Maintained: Buy | $30 | $17.64 | +70.07% | 2 | May 15, 2026 | |
| FATE Fate Therapeutics | Maintained: Buy | $7 | $2.06 | +239.81% | 4 | May 14, 2026 | |
| VOR Vor Biopharma | Maintained: Hold | $15 → $18 | $14.36 | +25.35% | 3 | May 14, 2026 | |
| SANA Sana Biotechnology | Maintained: Buy | $7 | $2.68 | +161.19% | 4 | May 13, 2026 | |
| NKTR Nektar Therapeutics | Maintained: Hold | $95 → $80 | $59.38 | +34.73% | 3 | May 11, 2026 | |
| IMA ImageneBio | Maintained: Sell | $2 | $5.62 | -64.41% | 3 | May 11, 2026 | |
| ACRS Aclaris Therapeutics | Maintained: Buy | $10 | $4.32 | +131.48% | 7 | May 8, 2026 | |
| ZURA Zura Bio | Maintained: Buy | $15 | $3.70 | +305.41% | 3 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 → $85 | $69.89 | +21.62% | 6 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $19.80 | +127.27% | 6 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $42.24 | +8.90% | 1 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $45 | $56.07 | -19.74% | 2 | Aug 7, 2025 |
Cartesian Therapeutics
May 27, 2026
Maintained: Buy
Price Target: $38
Current: $9.51
Upside: +299.58%
Artiva Biotherapeutics
May 21, 2026
Maintained: Buy
Price Target: $40
Current: $8.54
Upside: +368.38%
First Tracks Biotherapeutics
May 15, 2026
Maintained: Buy
Price Target: $30
Current: $17.64
Upside: +70.07%
Fate Therapeutics
May 14, 2026
Maintained: Buy
Price Target: $7
Current: $2.06
Upside: +239.81%
Vor Biopharma
May 14, 2026
Maintained: Hold
Price Target: $15 → $18
Current: $14.36
Upside: +25.35%
Sana Biotechnology
May 13, 2026
Maintained: Buy
Price Target: $7
Current: $2.68
Upside: +161.19%
Nektar Therapeutics
May 11, 2026
Maintained: Hold
Price Target: $95 → $80
Current: $59.38
Upside: +34.73%
ImageneBio
May 11, 2026
Maintained: Sell
Price Target: $2
Current: $5.62
Upside: -64.41%
Aclaris Therapeutics
May 8, 2026
Maintained: Buy
Price Target: $10
Current: $4.32
Upside: +131.48%
Zura Bio
May 8, 2026
Maintained: Buy
Price Target: $15
Current: $3.70
Upside: +305.41%
Apr 15, 2026
Maintained: Buy
Price Target: $45 → $85
Current: $69.89
Upside: +21.62%
Mar 17, 2026
Maintained: Buy
Price Target: $45
Current: $19.80
Upside: +127.27%
Feb 26, 2026
Reiterated: Buy
Price Target: $46
Current: $42.24
Upside: +8.90%
Aug 7, 2025
Maintained: Buy
Price Target: $40 → $45
Current: $56.07
Upside: -19.74%